生命科学资讯

Roche targets becoming top 3 obesity player as experimental drug enters late-stage trial - CNBC

RION Engages Lonza to Scale Manufacturing Exosome Based Therapeutics - Business Wire

RION Partners with Lonza for Scalable Exosome-Based Drug Manufacturing - Contract Pharma

Lonza Agrees to Scale Manufacturing for RION’s Exosome-Based Therapeutics - GEN - Genetic Engineering and Biotechnology News

Geriatrician Roche appointed Professor Emeritus of Internal Medicine - UT Southwestern Medical Center

Roche pushes a novel myeloma target | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Roche's 'top three' obesity ambition not reliant on developing one megablockbuster - Fierce Biotech

Roche looks earlier with divarasib | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Illumina to develop KRAS companion diagnostics with multiple pharma partners - FirstWord Pharma

Illumina advances personalized cancer care with new pharma development partnerships - PR Newswire

Thermo Fisher Scientific’s Valuation: Assessing New Launches and Upgraded Outlook - Yahoo Finance

Here's Why Lonza Group (LZAGY) Is a Great 'Buy the Bottom' Stock Now - Nasdaq

Here's Why Lonza Group (LZAGY) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance

Roche, muscling into weight-loss drug race, advances obesity treatment to late-stage trial - Reuters

Roche CEO, pharma execs to meet with Swiss government over US tariffs - Reuters

Illumina sued by rival Element over gene-sequencing technology - Reuters

Lunit and Agilent Technologies Announce Collaboration to Enhance Development of Companion Diagnostic Solutions Powered with AI for Precision Medicine - PR Newswire

Thermo Fisher Scientific Launches the Thermo Scientific Hypulse Surface Analysis System to Accelerate the Understanding of Material Surfaces - Business Wire

Jessup Lonza Club serves up first Lonza competition - fox56.com

Jason Berndt ’01 Joins Lonza as New Head of Group Operations, Executive VP - West Point Association of Graduates